Given the critical roles of MyD88 and TLR4 in AAA, bone marrow transplantation is performed to determine whether the effect of MyD88 or TLR4 deficiency on AngII-induced AAA is mediated by cells of the hematopoietic lineage. This evidence concerns the gene MYD88 and triple-A syndrome.